Patients value hospital rankings when making decisions about their healthcare. Rankings, such as the US News and World Report (USNWR) integrate safety, outcome, and reputation metrics, however it is unknown whether these rankings are robust to surgery type, or if meaningful differences exist within top performing strata. Therefore, we aimed to study the associations of USNWR ranking and outcome measures using national registry data.
INTRODUCTION AND OBJECTIVES:
Patients value hospital rankings when making decisions about their healthcare. Rankings, such as the US News and World Report (USNWR) integrate safety, outcome, and reputation metrics, however it is unknown whether these rankings are robust to surgery type, or if meaningful differences exist within top performing strata. Therefore, we aimed to study the associations of USNWR ranking and outcome measures using national registry data.
METHODS: We used the Vizient CDB a hospital registry representing care at 97% of academic centers to analyze outcomes for urologic surgeries from 2014 through 2018. We compiled the following hospital outcomes on mortality, length of stay (LOS), 30-day readmissions, LOS index (observed/expected ratios), case mix index and patient safety and adverse event composite (PSI-90) for radical prostatectomy (RP), cystectomy (RC) and radical nephrectomy (RN). We studied the associations of USNWR "Top 50 Hospitals" and outcome by surgery type and in aggregate.
RESULTS: We identified 20,888 cases including 8,385 RP, 7,486 RN and 5,017 RC during the study period. Case volume was significantly higher in top 10 hospitals for RP, RC, and RN compared to 11-20 that was the second group with highest volume (1,700 more cases for RP, 1,806 for RN and 490 for RC; P <0.001). Hospital LOS was significantly lower in the upper quintile for RP (P <0.001) and RN (P<0.001) but not in RC. Adjusting for expected ratios, LOS index was similar in RP among the different quintiles but was lower for RN. 30-day readmission in upper quintile was significantly lower in RP only compared to 41-50 but similar to 11-40 institutions There was not significant variation in mortality between groups or procedures. Bottom ranking positions were negatively correlated with surgical volume (RP rho: -0.50, P<0.001; RN rho -0.41, P 0.005; RC rho: -0.42, P 0.0013) and positively correlated with mean LOS for RP (rho 0.45, P 0.002) and RC (rho 0.48, P 0.001). No other significant differences were found for the other variables. Comparing outcomes individually by hospitals, no significant differences or trends were found favoring top hospitals for LOS, mortality, costs, readmissions or PSI-90.
CONCLUSIONS: USNWR ranking of top urology programs was associated with better measures of patient outcome including mortality, readmission, and length of stay when grouped by quintiles and remained consistent across major cancer surgery types. There were no significant differences in outcome within deciles of rank, suggesting that categories of performance rather than ordinal position may be sufficient to describe hospital quality.
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MP29-20 EPIDEMIOLOGY OF GENITOURINARY FOREIGN BODIES IN THE UNITED STATES EMERGENCY ROOM SETTING AND ITS ASSOCIATION WITH MENTAL HEALTH DISORDERS
Dayron Rodriguez*, Nannan Thirumavalavan, Dallas, TX; Michel Apoj, Ricardo Munarriz, Boston, MA INTRODUCTION AND OBJECTIVES: The epidemiology of genito-urinary foreign bodies (GUFB) has been mainly reported through case reports and small series. The aim of this study is to investigate the epidemiology, the medical-socio-economic factors associated with GUFB and the cost in the United States emergency room setting.
METHODS: Emergency Department (ED) visits with the primary diagnosis of a genito-urinary foreign body (based on ICD-9 codes 939.0-939.9) between 2010-2014 were abstracted from the Nationwide Emergency Department Sample database.
RESULTS: Between 2010 and 2014, a weighted estimate of 120,223 visits to the ED with GUFB were recorded in the US, representing a national incidence of 7.6 ED visits per 100,000 persons. 4.68% of ED visits resulted in admissions and males were more likely to be admitted (24.8% vs 2.1%, p < 0.01). A third of patients had low income, 30% had no medical insurance, and a third of patients had Medicaid. Urethra/bladder and penile foreign bodies had a significant association with mental health disorders when compared to vulvar/ vaginal foreign bodies (35.6% vs. 6.1%, p < 0.001). Costs of managing patients in the ED averaged $3,769. More importantly, penile or urethra/ bladder foreign bodies incurred a higher cost ($30,071) .
CONCLUSIONS: This is the largest population-based study investigating the epidemiology of genito-urinary foreign bodies, which occurs at a higher incidence than expected. GUFB are more common in young women and the majority of them are vulvar/vaginal. Penile and urethral/bladder foreign bodies occurred in older male patients and are associated with longer hospital stays and costs. Mental health disorders were more common in male patients and in cases of urethral/bladder foreign bodies.
INTRODUCTION AND OBJECTIVES:
Clinical guidelines recommended performing multiparametric magnetic resonance imaging (mpMRI) and fusion targeting any mpMRI lesions in the repeat-biopsy setting. However, its role in biopsy-ïve men remained controversial. We synthesized current evidence based on well-designed randomized controlled trials (RCTs) to investigate the role of prebiopsy mpMRI and MRI/TRUS fusion targeted biopsy (TB) for prostate cancer (PCa) diagnosis in biopsy-na ave men.
METHODS: A systematic review of PubMed (Medline), Embase, Ovid and the Cochrane Library up to 1st October 2018 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. The statistical analyses were performed with Revman 5.3. We compared the diagnostic accuracy between the intervention group (using prebiopsy mpMRI to select patients for TB) and the control group (standard biopsy regardless of MRI results) by calculating the risk ratio (RR) with 95% confidence intervals (CIs) of overall PCa and clinically significant PCa (csPCa) detection rates (DRs). Subgroup analysis was performed to highlight the independent role of SB and MRI/TRUS fusion TB by stratifying patients of different biopsy approach.
RESULTS: Six RCTs with 2187 participants were evaluated. Pooled analysis revealed slight higher overall PCa DRs of 62.7% (687/ 1095) in the intervention group compared with that of 41.3% (451/1092) in the control group (RR 1.40, 95% CI: 1.00-1.95) [ Figure 1 ]. And there was a trend favoring the use mpMRI before biopsy which detected more csPCa (42.8%, 206/481) compared with SB only in the control group (31.6%, 152/481) (RR 1.36, 95% CI: 0.95-1.95) [ Figure 2 ]. Further analysis revealed positive prebiopsy mpMRI with MRI/fusion TB detected more csPCa (52.9%, 193/365) in the intervention group compared with SB only without any mpMRI in the control group (31.6%, 152/481) (RR 1.64, 95% CI 1.06-2.52) [ Figure 3 ]. However, SB helped detect missed PCa for patients of negative mpMRI (23.5%, 20/85) and nearly half of the tumors were clinically significant.
CONCLUSIONS: The use of prebiopsy mpMRI may help improve overall PCa and csPCa DRs in biopsy-na ave men. However, SB may play a role in detecting missed PCa for patients of negative mpMRI.
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